Spoken Alpha
Lyra Therapeutics, Inc.
Lyra Therapeutics, Inc is a Healthcare company operating in Biotechnology with a $354,976 market cap.
Most recent reported earnings: Q1 FY2026 (Mar 30, 2026).
3 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LYRA.
$ curl https://api.spokenalpha.com/v1/companies/LYRAFAQ
Spoken Alpha indexes LYRA's earnings call transcripts at https://spokenalpha.com/companies/LYRA. Each call links to attributed speakers and parsed analyst Q&A.
Lyra Therapeutics, Inc. (LYRA) held its most recent earnings call on 2021-11-09, covering fiscal Q3 2021.
Lyra Therapeutics, Inc. (LYRA) operates in the Healthcare sector (Biotechnology industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | 2026-03-30 | $-3.92 | — | — | — | — | — | EODHD |
| Q3 FY2025 | 2025-11-11 | $-3.40 | $-4.07 | +16.5% | $25.0K | — | — | EODHD |
| Q2 FY2025 | 2025-08-11 | $-5.22 | $-4.78 | -9.2% | $183.0K | — | — | EODHD |
| Q1 FY2025 | 2025-05-05 | $-6.50 | $-6.83 | +4.8% | $183.0K | — | — | EODHD |
| Q4 FY2024 | 2025-03-18 | $-0.14 | $-0.13 | -9.2% | $209.0K | — | — | EODHD |
| Q3 FY2024 | 2024-11-11 | $-6.92 | $-10.25 | +32.5% | $195.0K | — | — | EODHD |
| Q2 FY2024 | 2024-08-13 | $-12.95 | $-16.40 | +21.0% | $598.0K | — | — | EODHD |
| Q1 FY2024 | 2024-04-29 | $-17.50 | $-13.40 | -30.6% | $532.0K | — | — | EODHD |
| Q4 FY2023 | 2024-03-20 | $-0.22 | $-0.31 | +29.0% | $146.0K | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $-13.50 | $-14.75 | +8.5% | $544.0K | — | — | EODHD |
| Q2 FY2023 | 2023-08-07 | $-16.05 | $-21.50 | +25.4% | $458.0K | — | — | EODHD |
| Q1 FY2023 | 2023-05-11 | $-0.44 | $-0.36 | -22.2% | $410.0K | — | — | EODHD |
| Q4 FY2022 | 2023-03-28 | $-15.75 | $-20.87 | +24.5% | $11.0K | — | — | EODHD |
| Q3 FY2022 | 2022-11-07 | $-20.00 | $-22.37 | +10.6% | $359.0K | — | — | EODHD |
| Q2 FY2022 | 2022-08-08 | $-21.50 | $-17.00 | -26.5% | $525.0K | — | — | EODHD |
| Q1 FY2022 | 2022-05-09 | $-0.54 | $-0.91 | +40.7% | $468.0K | — | — | EODHD |
| Q4 FY2021 | 2022-03-08 | $-52.50 | $-39.50 | -32.9% | $271.0K | — | — | EODHD |
| Q3 FY2021 | 2021-11-08 | $-42.50 | $-36.75 | -15.7% | $14.0K | — | — | EODHD |
| Q2 FY2021 | 2021-08-08 | $-42.50 | $-33.50 | -26.9% | $0 | — | — | EODHD |
| Q1 FY2021 | 2021-05-10 | $-30.00 | $-26.50 | -13.2% | $0 | — | — | EODHD |
Source: EODHD. LYRA reported actuals as published; sparse fields render as —.